InVivoMAb anti-mouse CD317 (BST2, PDCA-1)

Bradley KC, Finsterbusch K, Schnepf D, et al. Microbiota-Driven Tonic Interferon Signals in Lung Stromal Cells Protect from Influenza Virus Infection. Cell Rep. 2019,28(1):245-256.e4. doi: 10.1016/j.celrep.2019.05.105

Nash WT, Gillespie AL, Brown MG. Murine Cytomegalovirus Disrupts Splenic Dendritic Cell Subsets via Type I Interferon-Dependent and -Independent Mechanisms. Front Immunol. 2017,8:251. doi: 10.3389/fimmu.2017.00251

Toivonen R, Kong L, Rasool O, et al. Activation of Plasmacytoid Dendritic Cells in Colon-Draining Lymph Nodes during Citrobacter rodentium Infection Involves Pathogen-Sensing and Inflammatory Pathways Distinct from Conventional Dendritic Cells. J Immunol. 2016,196(11):4750-9. doi: 10.4049/jimmunol.1600235

Moniz RJ, Chan AM, Gordon LK, et al. Plasmacytoid dendritic cells modulate nonprotective T-cell responses to genital infection by Chlamydia muridarum. FEMS Immunol Med Microbiol. 2010,58(3):397-404. doi: 10.1111/j.1574-695X.2010.00653.x

Rajagopal D, Paturel C, Morel Y, et al. Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists. Blood. 2010,115(10):1949-57. doi: 10.1182/blood-2009-08-238543

Schliemann C, Roesli C, Kamada H, et al. In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy. Blood. 2010,115(3):736-44. doi: 10.1182/blood-2009-08-239004

Blasius AL, Giurisato E, Cella M, et al. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol. 2006,177(5):3260-5.